Prosecution Insights
Last updated: August 17, 2026

Examiner: KNIGHT, TERESA E

Tech Center 1600 • Art Units: 1631 1632 1634 1657

This examiner grants 66% of resolved cases

Performance Statistics

65.7%
Allow Rate
+5.7% vs TC avg
509
Total Applications
+48.7%
Interview Lift
1249
Avg Prosecution Days
Based on 492 resolved cases, 2023–2026

Rejection Statute Breakdown

7.3%
§101 Eligibility
12.8%
§102 Novelty
45.4%
§103 Obviousness
23.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19441401 ADIPOSE-DERIVED REGENERATIVE CELL PREPARATIONS Non-Final OA Blue Cell Therapeutics ApS
18342088 STAINING METHOD, LIQUID COMPOSITION FOR STAINING, AND KIT FOR STAINING Non-Final OA CANON KABUSHIKI KAISHA
18296652 METHOD OF PRODUCING CELL PREPARATION FOR JOINT MEDICAL TREATMENT, CELL PREPARATION FOR JOINT MEDICAL TREATMENT, AND METHOD OF CULTURING MESENCHYMAL STEM CELL Final Rejection FUJIFILM Corporation
18483917 Therapeutic Supernatant from Cell-Seeded Substrates and Related Methods Non-Final OA The Regents of the University of California
18789888 BIOCHEMICAL AND BIOMECHANICAL CONDITIONING FOR ENHANCING PERSONALIZED MESENCHYMAL STEM CELL THERAPIES Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18559460 METHODS AND COMPOSITIONS FOR TRANSPORT, STORAGE, AND DELIVERY OF ADENO-ASSOCIATED VIRAL VECTOR AND OTHER MOLECULES Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month